Filing Details
- Accession Number:
- 0001493152-23-029445
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-18 16:21:49
- Reporting Period:
- 2023-08-17
- Accepted Time:
- 2023-08-18 16:21:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1321834 | Mymd Pharmaceuticals Inc. | MYMD | In Vitro & In Vivo Diagnostic Substances (2835) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1857479 | Paul Rivard | 855 N. Wolfe Street, Suite 601 Baltimore MD 21205 | Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-08-17 | 25,000 | $1.12 | 250,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
